Registry Data Show Vedolizumab, Ustekinumab Safe in Pregnancy

Use of concomitant medication in vedolizumab‐exposed pregnancies.

IBD and Pregnancy: Frequently Asked Questions - Canadian Digestive Health Foundation

Joost PH Drenth on X: Observational data from the adalimumab #PYRAMID registry of pregnant Crohn's disease patients @uegjournal ✓2⃣9⃣3⃣ pregnancies in #crohnsdisease ✓Biological therapy with #adalimumab 📌No adverse pregnancy outcomes @my_ueg

STELARA® (ustekinumab) One-Press Pre-Filled Pen, a New Patient Controlled Injector for Inflammatory Bowel Disease, is Now Approved for Use Within Ireland - Irish Pharmacy News

Efficacy and Safety of Ustekinumab for CD

Ulcerative Colitis and Pregnancy

JKMS :: Journal of Korean Medical Science

A review article of inflammatory bowel disease treatment and pharmacogenomics, Beni-Suef University Journal of Basic and Applied Sciences

Frontiers Effectiveness of vedolizumab and ustekinumab as second biologic agent in achieving target outcomes in tumor necrosis factor antagonists experienced patients with inflammatory bowel disease (enroll-ex study)

Evidence corner

Inflammatory bowel disease: treatment and management - The Pharmaceutical Journal

A review of pregnancy and lactation postmarketing studies required by the FDA - Krastein - 2023 - Pharmacoepidemiology and Drug Safety - Wiley Online Library

PDF) Ustekinumab Drug Levels in Maternal and Cord Blood in a Woman With Crohn's Disease Treated Until 33 Weeks of Gestation

Full article: Ustekinumab in treatment of Crohn's disease: design, development, and potential place in therapy